BamSEC and AlphaSense Join Forces
Learn More

Principia Biopharma Inc.

Formerly NASDAQ: PRNB
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.18
from 10-K 10 pages Principia Biopharma, Inc. Change in Control and Severance Agreement
12/34/56
EX-10.1
from 8-K 10 pages Principia Biopharma Inc. 400 East Jamie Court Suite 302 South San Francisco, Ca 94080 August 23, 2018 Dolca Thomas, M.D. Re: Offer of Employment Dear Dolca: Principia Biopharma Inc., a Delaware Corporation (The “Company”), Is Pleased to Offer You the Position of Chief Medical Officer, on the Following Terms. Employment and Duties Base Salary, Sign-On Bonus and Annual Bonus
12/34/56
EX-10.13
from S-1/A 123 pages License Agreement
12/34/56
EX-10.21
from S-1/A 18 pages Roy Hardiman Re: Offer of Employment Dear Roy: Principia Biopharma Inc. a Delaware Corporation (The “Company”), Is Pleased to Offer You the Position of Chief Business Officer, on the Following Terms: Employment and Duties
12/34/56
EX-10.20
from S-1/A 17 pages David Goldstein, Phd Re: Offer of Employment Dear David: Principia Biopharma Inc. a Delaware Corporation (The “Company”), Is Pleased to Offer You the Position of Vice President, Drug Discovery on the Following Terms
12/34/56
EX-10.19
from S-1/A 31 pages Employment and Duties
12/34/56
EX-10.11
from S-1/A 18 pages Stefani Wolff Re: Offer of Employment Dear Stefani: Principia Biopharma Inc. a Delaware Corporation (The “Company”), Is Pleased to Offer You the Position of Senior Vice President, Strategy and Operations, on the Following Terms: Employment and Duties
12/34/56
EX-10.10
from S-1/A 19 pages Chris Chai Re: Offer of Employment Dear Chris: Principia Biopharma Inc. a Delaware Corporation (The “Company”), Is Pleased to Offer You the Position of Chief Financial Officer, on the Following Terms: Employment and Duties
12/34/56
EX-10.9
from S-1/A 8 pages April 23, 2011 Martin Babler Re: Executive Employment Terms Dear Martin
12/34/56
EX-10.8
from S-1/A 17 pages Principia Biopharma Inc. Indemnity Agreement
12/34/56
EX-10.7
from S-1/A 12 pages Principia Biopharma, Inc. 2018 Employee Stock Purchase Plan Adopted by the Board of Directors: August 28, 2018 Approved by the Stockholders: August 30, 2018 Ipo Date/Effective Date: [ ], 2018
12/34/56
EX-10.6
from S-1/A 10 pages Principia Biopharma, Inc. Change in Control and Severance Agreement
12/34/56
EX-10.5
from S-1/A 11 pages Principia Biopharma, Inc. Stock Option Grant Notice
12/34/56
EX-10.4
from S-1/A 27 pages Principia Biopharma, Inc. 2018 Equity Incentive Plan Adopted by the Board of Directors: August 28, 2018 Approved by the Stockholders: August 30, 2018 Ipo Date/Effective Date: [ ], 2018
12/34/56
EX-10.18
from S-1 74 pages Lease Britannia Pointe Grand Business Park Britannia Pointe Grand Limited Partnership a Delaware Limited Partnership, as Landlord, and Principia Biopharma, Inc., a Delaware Corporation, as Tenant
12/34/56
EX-10.17
from S-1 85 pages Lease Agreement
12/34/56
EX-10.16
from S-1 65 pages Lease Agreement
12/34/56
EX-10.15
from S-1 49 pages Amended and Restated Exclusive License Agreement Between the Regents of the University of California and Principia Biopharma Inc. for Inverted Kinase Inhibitors Otm Case No. Sf2011-045
12/34/56
EX-10.14
from S-1 51 pages Amended and Restated Exclusive License Agreement Between the Regents of the University of California and Principia Biopharma Inc. for Rsk Inhibitors and Novel Electrophiles Uc Case Nos. Sf2003-057 & Sf2009-119
12/34/56
EX-10.13
from S-1 123 pages License Agreement
12/34/56